Drug Safety

Patient safety is of paramount importance to Jazz Pharmaceuticals. It is our ethical and regulatory responsibility to monitor the safety of the medicines we develop from their preclinical stage through clinical testing and prescribing. Timely reporting to Drug Safety is critical to enable compliance with regulatory requirements.

If you are a patient reporting occurrence of adverse events or if you have questions about your condition, please contact your health care practitioner.

Reporting an Adverse Event or Product Complaint in North America

Please call 1-800-520-5568 to report an adverse event or a product complaint for Defitelio^®, Rylaze^®, Sunosi^®, Vyxeos^®, Xyrem^®, Xywav^™ or Zepzelca^® in the U.S.; or Defitelio^®, Sunosi^®, Vyxeos^®, Xyrem^®, or Zepzelca^™ in Canada.

Additionally, adverse events or product complaints where the package indicates the product Erwinaze^® (in the U.S.) or Erwinase^® (in Canada) is distributed by Jazz, may also be reported using the contact information below.

Reporting an Adverse Event or Product Complaint in Europe and International

To report an adverse event or a product complaint for Defitelio^®, Kidrolase^®, Sunosi^® or Vyxeos^® Liposomal, please call using one of the country-specific telephone numbers listed below.

Additionally, adverse events or product complaints where the package indicates the product Erwinase^® is distributed by Jazz, may also be reported using the contact information below.

Our Pharmacovigilance Privacy Notice outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report.